Paeds Vivas · nephrology-urology-fluids-and-electrolytes
Kidney transplantation in children: Viva
Branching clinical structured oral on paediatric kidney transplantation: the rationale for preemptive living-donor transplant, the standard tacrolimus-based immunosuppression regimen with therapeutic drug monitoring, the systematic investigation of a rising creatinine, and the distinction between acute rejection, calcineurin inhibitor toxicity and BK virus nephropathy.
On this page & tools
Target exams
Branch 1: Rationale for preemptive living-donor transplant
The candidate should state that kidney transplantation is the treatment of choice over lifelong dialysis for a child with end-stage kidney disease because it improves survival, growth, quality of life and neurodevelopment. A strong candidate should explain that two factors independently predict superior graft survival: a living-donor kidney and a preemptive transplant performed before dialysis begins. The living-donor kidney, especially from a parent, survives longest because the kidney is healthy, the surgery is elective and the cold ischaemia time is short. A preemptive transplant avoids the morbidity of dialysis itself. [2]
If the examiner asks when to plan the transplant, the candidate should state that a preemptive transplant should be planned once the estimated glomerular filtration rate approaches 10 to 15 mL per minute per 1.73 square metres, because at that point dialysis is imminent. The living donor workup must be complete before dialysis is needed so the child never starts dialysis. This girl, with an eGFR of 13, is exactly at that threshold, so her father's donor workup should be expedited. [2]
You have read the opening of this viva. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship atlas.
References6Show ledgerHide ledger
- [1]Roach JP, Bock ME, Goebel J Pediatric kidney transplantation. Semin Pediatr Surg, 2017.PMID 28964479
- [2]Winterberg PD, Garro R Long-Term Outcomes of Kidney Transplantation in Children. Pediatr Clin North Am, 2019.PMID 30454748
- [3]Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant, 2009.PMID 19845597
- [4]Weber LT Therapeutic drug monitoring in pediatric renal transplantation. Pediatr Nephrol, 2015.PMID 24763544
- [5]Ng YW, Singh M, Sarwal MM Antibody-mediated rejection in pediatric kidney transplantation: pathophysiology, diagnosis, and management. Drugs, 2015.PMID 25813498
- [6]Scaggs Huang FA, Danziger-Isakov L Infectious disease risks in pediatric renal transplantation. Pediatr Nephrol, 2019.PMID 29626241